No Data
No Data
No Data
Express News | Scisparc Ltd - All Outstanding Shares of Automax Will Be Converted Into Right to Receive Ordinary Shares of Scisparc
Express News | Scisparc Ltd - Following Acquisition Scisparc Shareholders Will Hold Together About 50.01% of Share Capital of Post-Closing Combined Company
Express News | Scisparc Ltd - Will Acquire 100% of Automax and Establish a New Wholly-Owned Israeli Subsidiary
Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds Under Its SciSparc Ltd Collaboration
Clearmind Medicine Inc. ((Nasdaq, CSE:CMND), (FSE: CWY) ("Clearmind" or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
TEL AVIV, Israel, Jan. 24, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders
Why SciSparc Ltd Stock Is Blasting Higher
SciSparc Ltd. (NASDAQ:SPRC) shares are trading higher Friday after the company announced it has launched a clinical trial of its combination of cannabidiol (CBD) and SciSparc's proprietary Palmitoylet
No Data